title: Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement.
authors.affiliation: Department of Psychiatry, University of Toronto, ECW-3D Bathurst Street, Toronto, Ontario M5T 2SB, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Montplaisir
authors.forename: R
authors.initials: R
authors.lastname: Hawa
authors.forename: H
authors.initials: H
authors.lastname: Moller
authors.forename: C
authors.initials: C
authors.lastname: Morin
authors.forename: M
authors.initials: M
authors.lastname: Fortin
authors.forename: J
authors.initials: J
authors.lastname: Matte
authors.forename: L
authors.initials: L
authors.lastname: Reinish
authors.forename: C M
authors.initials: CM
authors.lastname: Shapiro
mesh_terms: D000081:Acetamides / Q000009:adverse effects / Q000627:therapeutic use*; D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D053961:Azabicyclo Compounds; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use*; D002170:Canada; D032921:Consensus; D004347:Drug Interactions; D017723:Drug Utilization Review / Q000592:standards; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use*; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*
chemical_list: D000081:Acetamides; D014151:Anti-Anxiety Agents; D053961:Azabicyclo Compounds; D006993:Hypnotics and Sedatives; D010879:Piperazines; D011743:Pyrimidines; C515050:zopiclone; D001569:Benzodiazepines; C085665:zaleplon